MPI Investment Management’s AbbVie ABBV Stock Holding History

MPI Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$2.97M	Buy	+30,748	New	+$2.9M	3.56%	3

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

MPI Investment Management's ABBV Position: Q4 2017 in Review

MPI Investment Management opened a new position in AbbVie (ABBV) in Q4 2017: 30,748 shares worth $2.97M. The stake represents 3.56% of the portfolio and ranks #3 among its holdings.

2,000 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

MPI Investment Management held 30,748 shares of AbbVie worth $2.97M as of Q4 2017.
AbbVie was a new MPI Investment Management position in Q4 2017.
AbbVie made up 3.56% of MPI Investment Management's portfolio in Q4 2017, its #3 holding.
2,000 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on MPI Investment Management's 13F filing for Q4 2017, filed 6 Feb 2018.